Iodine-123 labelled nor-β-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats

European Journal of Nuclear Medicine

Volumn 25, Issue 12, 1998, Pages 1666-1669

  Booij, Jan ^a   Knol, Remco J J ^b   Reneman, Liesbeth ^b   De Bruin, Kora ^b   Janssen, Anton G M ^b   Van Royen, Eric A ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

2 carbomethoxy 3 (4 iodophenyl)nortropane; Biodistribution studies; Hypothalamus; Serotonin transporter

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; FLUVOXAMINE; IODINE 123; NORTROPANE DERIVATIVE; RADIOLIGAND; SEROTONIN TRANSPORTER; VANOXERINE;

ARTICLE; CORPUS STRIATUM; HYPOTHALAMUS; ISOTOPE LABELING; NONHUMAN; RAT; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BRAIN; CARRIER PROTEINS; COCAINE; DOPAMINE UPTAKE INHIBITORS; FLUVOXAMINE; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PIPERAZINES; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TROPANES;

EID: 0032418807     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050346     Document Type: Article

References (15)

1. Tejani-Butt SM, Yang J, Pawlyk AC. Altered serotonin transporters in Alzheimer's disease raphe and hippocampus. NeuroReport 1995; 6: 1207-1210.
2. Squier MV, Jalloh S, Hilton-Jones D, Series H. Death after ecstasy ingestion: neuropathological findings. J Neurol Neurosurg Psychiatry 1995; 58: 756.
3. Boja JW, Kuhar MJ, Kopajtic T, et al. Secondary amine analogues of 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters. J Med Chem 1994; 37: 1220-1223.
4. Bergström KA, Halldin C, Hall H, et al. In vitro and in vivo characterisation of nor-β-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain. Eur J Nucl Med 1997; 24: 596-601.
5. Hiltunen J, Åkerman KK, Kuikka JT, et al. Iodine-123 labelled nor-β-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. Eur J Nucl Med 1998; 25: 19-23.
6. Claassen V, Davies JE, Hertting G, Placheta P. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol 1977; 60: 505-516.
7. Andersen PH. The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 1989; 166: 493-504.
8. Kuhar MJ, Aghajanian GK, Roth RH. Trytophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: correlations with serotonin levels and histochemical fluorescence. Brain Res 1972; 44: 165-176.
9. 3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res 1989; 486: 261-268.
10. 3H]GBR12935 binding to dopamine transporters in the human brain. J Neurochem 1989; 53: 1400-1404.
11. Rijks LJM, Booij J, Doornbos T, et al. In vitro and in vivo characterization of newly developed iodinated 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}piperazine derivatives in rat; limited value as dopamine transporter SPECT ligands. Synapse 1996; 23: 201-207.
12. 123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. Synapse 1997; 27: 183-190.
13. 123I]5-iodo-6-nitroquipazine. Eur J Pharmacol 1993; 242: 189-193.
14. Jagust WJ, Eberling JL, Biegon A, et al. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J Nucl Med 1996; 37: 1207-1214.
15. Yeghiayan SK, Andersen SL, Baldessarini RJ. Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi. Neurosci Lett 1997; 236: 147-150.